Remnant cholesterol as a lipid-lowering target may have a long way to go.

Cao, Ye-Xuan; Dou, Ke-Fei; Li, Jian-Jun

Cao, Ye-Xuan; Dou, Ke-Fei; Li, Jian-Jun.

Afiliación

Cao YX; Cardio-Metabolic Center, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, BeiLiShi Road 167, Beijing 100037, China.
Dou KF; Heart Center & Beijing Key Laboratory of Hypertension, Beijing Chaoyang Hospital, Capital Medical University, Beijing 100020, China.
Li JJ; Cardio-Metabolic Center, State Key Laboratory of Cardiovascular Disease, Fu Wai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, BeiLiShi Road 167, Beijing 100037, China.

Eur Heart J ; 44(36): 3481-3482, 2023 09 21.

Article en En | MEDLINE | ID: mdl-37322602

Asunto(s)

Colesterol; Humanos; Triglicéridos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Colesterol Límite: Humans Idioma: En Revista: Eur Heart J Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google